Q-TWiST analysis of patients receiving temsirolimus or interferon alpha for treatment of advanced renal cell carcinoma. [electronic resource]
Producer: 20101029Description: 577-84 p. digitalISSN:- 1179-2027
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Interferon Type I -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Quality-Adjusted Life Years
- Recombinant Proteins
- Sirolimus -- administration & dosage
- Surveys and Questionnaires
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.